The U.S. Remains Preferred Market for Launching New Products, According to Tufts Center for the Study of Drug Development
November 12, 2008 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - November 12, 2008) - While the number of annual new drug approvals in
the United States has declined during the past decade, the U.S. remains the
preferred market for...
Adaptive Technologies Expert Illustrates Impact of Data Mining Intelligence at Advanced School of Marketing Research Conference
November 10, 2008 13:30 ET
|
Adaptive Technologies, Inc.
PHOENIX, AZ--(Marketwire - November 10, 2008) -
Who:
Chris Stephens, PhD., Vice President Research & Development at Adaptive
Technologies, Inc., (ATi) and Professor, Institute for Nuclear...
Open Innovation Leaders Gather to Share Best Practices at NineSigma's OI Leadership Summit 2008
October 30, 2008 11:23 ET
|
NineSigma, Inc.
CLEVELAND, OH--(Marketwire - October 30, 2008) - Earlier this month, open innovation leaders
from around the world gathered at NineSigma's Open Innovation Leadership
Summit 2008 to share best...
Clinical Trial Design Holds Key to Improved Drug Development Efficiency, According to Tufts Center for the Study of Drug Development
October 30, 2008 10:10 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - October 30, 2008) - Improved protocol design, perhaps more than any
other drug development stratagem, holds the key to faster and more
efficient development, according to...
Fast Track Drugs Reach Market Sooner, According to Tufts Center for the Study of Drug Development
September 03, 2008 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - September 3, 2008) - New drugs that receive fast track designation by
the U.S. Food and Drug Administration (FDA) experience shorter clinical and
approval times compared to...
NineSigma Named to Inc. 5000 List of Fastest-Growing Private Companies
August 26, 2008 10:23 ET
|
NineSigma
CLEVELAND, OH--(Marketwire - August 26, 2008) - NineSigma, the leading provider of open innovation solutions for fortune
1000 companies, today announced that it has been named to the annual Inc.
5000...
H2scan Secures $4 Million in Series D Funding
July 29, 2008 17:49 ET
|
H2scan
VALENCIA, CA--(Marketwire - July 29, 2008) - H2scan Corporation today announced the Company
has secured $4 million in Series D funding from Chrysalix Energy Venture
Capital, H5 Capital, L.P.,...
Postmarketing Studies Are Becoming the Norm in the U.S., Europe, and Japan, According to Tufts Center for the Study of Drug Development
July 10, 2008 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - July 10, 2008) - Post-approval study commitments, in which drug
developers, as a condition of regulatory approval, agree to conduct
research on newly marketed prescription...
NineSigma's Paul Stiros to Participate in Open Innovation Discussion at September Gartner Summit
June 24, 2008 10:10 ET
|
NineSigma, Inc.
CLEVELAND, OH--(Marketwire - June 24, 2008) - NineSigma, the leading provider of
open innovation solutions, today announced that company president and CEO,
Paul Stiros, has been invited to...
NineSigma Appoints New Director of Business Development
June 19, 2008 10:34 ET
|
NineSigma, Inc.
CLEVELAND, OH--(Marketwire - June 19, 2008) - NineSigma, the leading provider of open innovation (OI)
solutions, today announced the appointment of David Kalasky as director of
business development....